This comes after the Justice Department sued to halt the deal earlier this year, calling it anticompetitive because Change Healthcare, which would be merged with UnitedHealth Group’s data and consulting business OptumInsight, has access to data from insurer customers.
UnitedHealth Group argued that Optum is separate from its insurance arm, UnitedHealthcare, and the deal should continue as there are policies in place to protect sensitive data.
The Justice Department did not respond to Reuters about why it dropped its appeal.
Following the dismissal, UnitedHealth Group’s shares went up 0.2 percent to $478.09, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
